You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 2, 2024

ATENOLOL; CHLORTHALIDONE - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


Summary for ATENOLOL; CHLORTHALIDONE
US Patents:0
Tradenames:3
Applicants:9
NDAs:10
Finished Product Suppliers / Packagers: 11
Clinical Trials: 4
DailyMed Link:ATENOLOL; CHLORTHALIDONE at DailyMed
Recent Clinical Trials for ATENOLOL; CHLORTHALIDONE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Federico II UniversityPhase 4
Agenzia Italiana del FarmacoPhase 4
US Department of Veterans Affairs

See all ATENOLOL; CHLORTHALIDONE clinical trials

Pharmacology for ATENOLOL; CHLORTHALIDONE
Anatomical Therapeutic Chemical (ATC) Classes for ATENOLOL; CHLORTHALIDONE

US Patents and Regulatory Information for ATENOLOL; CHLORTHALIDONE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Unichem ATENOLOL AND CHLORTHALIDONE atenolol; chlorthalidone TABLET;ORAL 213302-002 Nov 25, 2020 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Watson Labs ATENOLOL AND CHLORTHALIDONE atenolol; chlorthalidone TABLET;ORAL 073665-002 Jul 2, 1992 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Sun Pharm Industries ATENOLOL AND CHLORTHALIDONE atenolol; chlorthalidone TABLET;ORAL 073582-002 Apr 29, 1993 DISCN No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Twi Pharms ATENOLOL AND CHLORTHALIDONE atenolol; chlorthalidone TABLET;ORAL 072302-002 May 31, 1990 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Unichem ATENOLOL AND CHLORTHALIDONE atenolol; chlorthalidone TABLET;ORAL 213302-001 Nov 25, 2020 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ATENOLOL; CHLORTHALIDONE

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Twi Pharms TENORETIC 50 atenolol; chlorthalidone TABLET;ORAL 018760-002 Jun 8, 1984 ⤷  Sign Up ⤷  Sign Up
Twi Pharms TENORETIC 100 atenolol; chlorthalidone TABLET;ORAL 018760-001 Jun 8, 1984 ⤷  Sign Up ⤷  Sign Up
Twi Pharms TENORETIC 100 atenolol; chlorthalidone TABLET;ORAL 018760-001 Jun 8, 1984 ⤷  Sign Up ⤷  Sign Up
Twi Pharms TENORETIC 50 atenolol; chlorthalidone TABLET;ORAL 018760-002 Jun 8, 1984 ⤷  Sign Up ⤷  Sign Up
Twi Pharms TENORETIC 100 atenolol; chlorthalidone TABLET;ORAL 018760-001 Jun 8, 1984 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.